196 related articles for article (PubMed ID: 9676716)
1. Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilation in human coronary circulation.
Nishikawa Y; Kanki H; Ogawa S
J Cardiovasc Pharmacol; 1998 Jul; 32(1):21-8. PubMed ID: 9676716
[TBL] [Abstract][Full Text] [Related]
2. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
3. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
Aizawa T; Ogasawara K; Kato K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.
Nakae I; Quan L; Hashimoto K; Sugimoto Y; Tsutamoto T; Kinoshita M
Cardiovasc Drugs Ther; 1994 Feb; 8(1):137-45. PubMed ID: 8086324
[TBL] [Abstract][Full Text] [Related]
5. Coronary microvascular response to intracoronary administration of nicorandil.
Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs.
Berdeaux A; Drieu la Rochelle C; Richard V; Giudicelli JF
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S17-21. PubMed ID: 1282171
[TBL] [Abstract][Full Text] [Related]
7. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
Sakaino N; Araki H; Nishi K
Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.
Ghaleh B; Dubois-Randé JL; Hittinger L; Giudicelli JF; Berdeaux A
Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748
[TBL] [Abstract][Full Text] [Related]
9. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
10. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
Imagawa J; Akima M; Nabata H; Taira N
J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanism.
Nakae I; Matsumoto T; Horie H; Yokohama H; Omura T; Minai K; Matsui T; Nozawa M; Takahashi M; Sugimoto Y; Ito M; Izumi M; Nakamura Y; Mitsunami K; Kinoshita M
J Cardiovasc Pharmacol; 2000 Jun; 35(6):919-25. PubMed ID: 10836727
[TBL] [Abstract][Full Text] [Related]
12. Effective and safe dose of intracoronary nicorandil in man.
Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
[TBL] [Abstract][Full Text] [Related]
13. Effects of nicorandil on large epicardial coronary artery in conscious dogs.
Yamada A; Tomoike H; Hayashi Y; Nishijima H; Nakamura M
Arzneimittelforschung; 1987 Nov; 37(11):1252-5. PubMed ID: 2964242
[TBL] [Abstract][Full Text] [Related]
14. Coronary vasodilatory action after a single dose of nicorandil.
Suryapranata H; Serruys PW; De Feyter PJ; Verdouw PD; Hugenholtz PG
Am J Cardiol; 1988 Feb; 61(4):292-7. PubMed ID: 2963519
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
[TBL] [Abstract][Full Text] [Related]
16. Nicorandil and cardiovascular performance in patients with coronary artery disease.
Suryapranata H; MacLeod D
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S45-51. PubMed ID: 1282175
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of relaxant effects of nicorandil on the dog coronary artery.
Imai S; Ushijima T; Nakazawa M; Nabata H; Sakai K
Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):274-82. PubMed ID: 6228201
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine improves coronary and peripheral vascular function.
Andrews NP; Prasad A; Quyyumi AA
J Am Coll Cardiol; 2001 Jan; 37(1):117-23. PubMed ID: 11153725
[TBL] [Abstract][Full Text] [Related]
19. Failure of the sulfhydryl donor N-acetylcysteine (NAC) to reverse nitrate tolerance in large epicardial arteries and the venous capacitance system of the dog.
Münzel T; Holtz J; Mülsch A; Stewart DJ; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():26-8; discussion 64-7. PubMed ID: 2511688
[TBL] [Abstract][Full Text] [Related]
20. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
Kuromaru O; Sakai K
Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
